Product Information
SUMATRIPTAN 6 MG/0.5 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $15.0000 per ML under NDC 63323027301. Its NADAC has been published 95 times since Apr 23, 2014.
Strength
6 mg/.5mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323027301
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA079242On Market Since
4/12/2011
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has been published 95 times since Apr 23, 2014, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.0000 per ML |
|---|---|
| All-time high | $105.0240 (Jun 3, 2015) |
| All-time low | $14.4040 (Oct 22, 2025) |
| 52-week high | $15.0000 |
| 52-week low | $14.4040 |
| Median price | $105.0240 |
| Average price | $70.8438 |
| Largest weekly change | -86.3% (Oct 22, 2025) |
| Weeks tracked | 95 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $15.0000 per ML (NDC 63323027301), effective Jun 24, 2026.
How has the price of SUMATRIPTAN 6 MG/0.5 ML VIAL changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has declined 85.7%. It has been tracked across 95 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML VIAL?
Since Apr 23, 2014, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has ranged from a low of $14.4040 (Oct 22, 2025) to a high of $105.0240 (Jun 3, 2015), with a median of $105.0240 per ML.
Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML VIAL?
3 NADAC-published products share the same active ingredient, strength, and dosage form as SUMATRIPTAN 6 MG/0.5 ML VIAL, but none are currently priced below it.
Who manufactures SUMATRIPTAN 6 MG/0.5 ML VIAL?
SUMATRIPTAN 6 MG/0.5 ML VIAL (NDC 63323027301) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification